Skip to main content
. 2015 Sep 16;2:15016. doi: 10.1038/mto.2015.16

Table 1. Summary of oncolytic HSVs discussed in the text.

Virus Deletions Foreign gene/promoter insertion References
C134 Deletions in both copies of γ134.5 gene IRS1 gene under control of an HCMV immediate early promoter 20,74
d12.CALP ICP4 deletion Calponin promoter  
G207 Deletions in both copies of γ134.5 gene and disabling lacZ insertion within ICP6 gene LacZ 8,20,22,23,41,42,72
G47Δ Deletions of the γ134.5 and α47 genes and a disabling lacZ insertion within ICP6 gene LacZ 29,30
hrR3 In-frame insertion of the bacterial lacZ gene within ICP6 LacZ 22,23
HSV1716 Deletions in both copies of γ134.5 gene None 17,68
M002 Deletions in both copies of γ134.5 gene Murine IL-12 under the transcriptional control of the murine early-growth response-1 promoter (Egr-1) 13,45,60,70,72
NV1020 Deletion in thymidine kinase (tk) locus and across the joining region of the long and short components of the HSV-1 genome HSV-1 DNA fragment encoding the tk gene fused to the α gene promoter 41,43
NV1066 Same NV1020 Enhanced GFP, CMV promoter 9,43
oHSV-MDK-34.5 Deletions of ICP6 and ICP34.5 ICP34.5 expression driven by the midkine promoter 24
rRp450 Deletion of ICP6 Rat CYP2B1 44,49,50
rQNestin-34.5 Deletions in γ134.5 gene and in-frame gene-disrupting insertion of GFP within ICP6 gene ICP34.5 under control of a synthetic nestin promoter 11
rQT3 Deletions in ICP6 and γ134.5 Tissue inhibitor of metalloproteinases 3, HSV-1 immediate early 4/5 promoter 11

CMV, cytomegalovirus; GFP, green fluorescent protein; HCMV, human cytomegalovirus; HSV, herpes simplex virus.